[go: up one dir, main page]

WO2005113553A3 - Azinyl-imidazoazine und azinylcarboxamide - Google Patents

Azinyl-imidazoazine und azinylcarboxamide Download PDF

Info

Publication number
WO2005113553A3
WO2005113553A3 PCT/EP2005/004616 EP2005004616W WO2005113553A3 WO 2005113553 A3 WO2005113553 A3 WO 2005113553A3 EP 2005004616 W EP2005004616 W EP 2005004616W WO 2005113553 A3 WO2005113553 A3 WO 2005113553A3
Authority
WO
WIPO (PCT)
Prior art keywords
azinyl
imidazoazine
carboxamide
formula
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2005/004616
Other languages
English (en)
French (fr)
Other versions
WO2005113553A2 (de
Inventor
Hans-Georg Schwarz
Jens Frackenpohl
Achim Hense
Peter Loesel
Olga Malsam
Karl-Heinz Kuck
Gerhard Krautstrunk
Christian Arnold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Original Assignee
Bayer CropScience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer CropScience AG filed Critical Bayer CropScience AG
Priority to EP05737913A priority Critical patent/EP1751152A2/de
Priority to EA200602038A priority patent/EA200602038A1/ru
Priority to BRPI0511025-4A priority patent/BRPI0511025A/pt
Priority to JP2007511976A priority patent/JP2007536307A/ja
Priority to MXPA06013135A priority patent/MXPA06013135A/es
Priority to KR1020067025005A priority patent/KR20070033980A/ko
Priority to US11/579,703 priority patent/US20080293674A1/en
Priority to CA002566074A priority patent/CA2566074A1/en
Publication of WO2005113553A2 publication Critical patent/WO2005113553A2/de
Publication of WO2005113553A3 publication Critical patent/WO2005113553A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles
    • A01N43/521,3-Diazoles; Hydrogenated 1,3-diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Die Erfindung betrifft Azinyl-imidazoazine der Formel (I) sowie deren Salze und N-Oxide, (I), wobei die Symbole die in der Beschreibung angegebenen Bedeutungen haben, sowie Verfahren zu ihrer Herstellung und neue Zwischenprodukte. Erfindungsgemäß ist auch die Verwendung der Verbindungen der Formel (I) und der Zwischenprodukte zur Bekämpfung von tierischen Schädlingen und unerwünschten Mikroorganismen.
PCT/EP2005/004616 2004-05-10 2005-04-29 Azinyl-imidazoazine und azinylcarboxamide Ceased WO2005113553A2 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP05737913A EP1751152A2 (de) 2004-05-10 2005-04-29 Azinyl-imidazoazine und azinylcarboxamide
EA200602038A EA200602038A1 (ru) 2004-05-10 2005-04-29 Азинилимидазоазины и азинилкарбоксамиды
BRPI0511025-4A BRPI0511025A (pt) 2004-05-10 2005-04-29 azinil-imidazoazinas e azinilcarboxamidas
JP2007511976A JP2007536307A (ja) 2004-05-10 2005-04-29 アジニルイミダゾアジンおよびアジニルカルボキサミド
MXPA06013135A MXPA06013135A (es) 2004-05-10 2005-04-29 Azinil-imidazoazinas y azinilcarboxamidas.
KR1020067025005A KR20070033980A (ko) 2004-05-10 2005-04-29 아지닐 이미다조아진 및 아지닐 카복사미드
US11/579,703 US20080293674A1 (en) 2004-05-10 2005-04-29 Azinyl Imidazoazine and Azinyl Carboxamide
CA002566074A CA2566074A1 (en) 2004-05-10 2005-04-29 Azinyl imidazoazine and azinyl carboxamide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004022897.3 2004-05-10
DE102004022897A DE102004022897A1 (de) 2004-05-10 2004-05-10 Azinyl-imidazoazine

Publications (2)

Publication Number Publication Date
WO2005113553A2 WO2005113553A2 (de) 2005-12-01
WO2005113553A3 true WO2005113553A3 (de) 2006-01-05

Family

ID=34966730

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/004616 Ceased WO2005113553A2 (de) 2004-05-10 2005-04-29 Azinyl-imidazoazine und azinylcarboxamide

Country Status (13)

Country Link
US (1) US20080293674A1 (de)
EP (1) EP1751152A2 (de)
JP (1) JP2007536307A (de)
KR (1) KR20070033980A (de)
CN (1) CN1980926A (de)
BR (1) BRPI0511025A (de)
CA (1) CA2566074A1 (de)
DE (1) DE102004022897A1 (de)
EA (1) EA200602038A1 (de)
MX (1) MXPA06013135A (de)
TW (1) TW200607451A (de)
WO (1) WO2005113553A2 (de)
ZA (1) ZA200609252B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1831225A2 (de) 2004-11-19 2007-09-12 The Regents of the University of California Entzündungshemmende pyrazolopyrimidine
US7709468B2 (en) 2005-09-02 2010-05-04 Abbott Laboratories Imidazo based heterocycles
KR20120051760A (ko) 2006-04-04 2012-05-22 더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 키나제 길항물질
WO2008005908A2 (en) * 2006-07-07 2008-01-10 Forest Laboratories Holdings Limited Pyridoimidazole derivatives
DE102006043443A1 (de) * 2006-09-15 2008-03-27 Bayer Healthcare Ag Neue aza-bicyclische Verbindungen und ihre Verwendung
GB2467670B (en) 2007-10-04 2012-08-01 Intellikine Inc Chemical entities and therapeutic uses thereof
JP5869222B2 (ja) 2008-01-04 2016-02-24 インテリカイン, エルエルシー 特定の化学的実体、組成物および方法
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
WO2009114870A2 (en) 2008-03-14 2009-09-17 Intellikine, Inc. Kinase inhibitors and methods of use
WO2009114874A2 (en) 2008-03-14 2009-09-17 Intellikine, Inc. Benzothiazole kinase inhibitors and methods of use
WO2010006086A2 (en) 2008-07-08 2010-01-14 Intellikine, Inc. Kinase inhibitors and methods of use
WO2010006072A2 (en) 2008-07-08 2010-01-14 The Regents Of The University Of California Mtor modulators and uses thereof
DE102008041214A1 (de) 2008-08-13 2010-02-18 Bayer Cropscience Ag N-substituierte Azinylakyl-azincarboxamide und deren Analoge
EP2346508B1 (de) 2008-09-26 2016-08-24 Intellikine, LLC Heterocyclische kinasehemmer
AU2009305669A1 (en) 2008-10-16 2010-04-22 The Regents Of The University Of California Fused ring heteroaryl kinase inhibitors
US8476431B2 (en) 2008-11-03 2013-07-02 Itellikine LLC Benzoxazole kinase inhibitors and methods of use
JP5789252B2 (ja) 2009-05-07 2015-10-07 インテリカイン, エルエルシー 複素環式化合物およびその使用
KR101721280B1 (ko) 2009-08-17 2017-03-29 인텔리카인, 엘엘씨 헤테로사이클릭 화합물 및 이의 용도
US8980899B2 (en) 2009-10-16 2015-03-17 The Regents Of The University Of California Methods of inhibiting Ire1
JP2013522274A (ja) 2010-03-18 2013-06-13 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー 非生物的な植物ストレスに対する活性剤としてのアリールスルホンアミド類及びヘタリールスルホンアミド類
EP2571357B1 (de) 2010-05-21 2016-07-06 Infinity Pharmaceuticals, Inc. Chemische verbindungen, zusammensetzungen und verfahren zur kinasemodulation
JP2013543480A (ja) 2010-10-18 2013-12-05 ラクオリア創薬株式会社 Ttx−s遮断薬としてのアリールアミド誘導体
CA2817577A1 (en) 2010-11-10 2012-05-18 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
SG10201600179RA (en) 2011-01-10 2016-02-26 Infinity Pharmaceuticals Inc Processes for preparing isoquinolinones and solid forms of isoquinolinones
CN103491962B (zh) 2011-02-23 2016-10-12 因特利凯有限责任公司 激酶抑制剂的组合及其用途
EA201490152A1 (ru) 2011-06-24 2014-05-30 Эмджен Инк. Антагонисты trpm8 и их применение при лечении
JP2014517074A (ja) 2011-06-24 2014-07-17 アムジエン・インコーポレーテツド Trpm8アンタゴニストおよび治療におけるそれらの使用
EP2734520B1 (de) 2011-07-19 2016-09-14 Infinity Pharmaceuticals, Inc. Heterocyclische verbindungen und ihre verwendung
MX2014000648A (es) 2011-07-19 2014-09-25 Infinity Pharmaceuticals Inc Compuestos heterociclicos y sus usos.
KR20140075693A (ko) 2011-08-29 2014-06-19 인피니티 파마슈티칼스, 인코포레이티드 헤테로사이클릭 화합물 및 그의 용도
MX370814B (es) 2011-09-02 2020-01-08 Univ California Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
SG11201502331RA (en) 2012-09-26 2015-04-29 Univ California Modulation of ire1
HUE040126T2 (hu) 2012-11-01 2019-02-28 Infinity Pharmaceuticals Inc Rákok kezelése PI3 kináz izoform modulátorok alkalmazásával
US9481667B2 (en) 2013-03-15 2016-11-01 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
CN103351348A (zh) * 2013-07-15 2013-10-16 黄河三角洲京博化工研究院有限公司 一种2-甲胺基嘧啶盐酸盐的合成方法
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
MX389256B (es) 2013-10-04 2025-03-20 Infinity Pharmaceuticals Inc Compuestos heterociclicos y usos de los mismos.
WO2015143012A1 (en) 2014-03-19 2015-09-24 Infinity Pharmaceuticals, Inc. Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
WO2015160975A2 (en) 2014-04-16 2015-10-22 Infinity Pharmaceuticals, Inc. Combination therapies
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP4585268A3 (de) 2015-09-14 2025-10-15 Twelve Therapeutics, Inc. Feste formen von isochinolinonderivaten, herstellungsverfahren, zusammensetzungen damit und verfahren zur verwendung davon
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
UA125216C2 (uk) 2016-06-24 2022-02-02 Інфініті Фармасьютікалз, Інк. Комбінована терапія
WO2019232403A1 (en) 2018-06-01 2019-12-05 Cornell University Combination therapy for pi3k-associated disease or disorder
BR112021012991A2 (pt) * 2018-12-31 2021-09-14 Syngenta Crop Protection Ag Derivados heterocíclicos pesticidamente ativos com substituintes contendo enxofre

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0692482A2 (de) * 1994-07-12 1996-01-17 Nihon Bayer Agrochem K.K. 1-Pyridyltetrazolinon-Derivate
WO1998057969A1 (de) * 1997-06-16 1998-12-23 Hoechst Schering Agrevo Gmbh 4-haloalkyl-3-heterocyclylpyridine und 4-haloalkyl-5-heterocyclylpyrimidine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
DE19858193A1 (de) * 1998-12-17 2000-06-21 Aventis Cropscience Gmbh 4-Trifluormethyl-3-oxadiazolylpyridine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
WO2001014373A1 (en) * 1999-08-20 2001-03-01 Syngenta Participations Ag Derivatives of trifluoromethylpyri(mi)dine
EP1140921A1 (de) * 1998-12-17 2001-10-10 Aventis CropScience GmbH 4-trifluormethyl-3-oxazolylpyridine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
WO2002012229A1 (de) * 2000-08-08 2002-02-14 Bayer Cropscience Gmbh Heterocyclylalkylazol-derivate und ihre verwendung als schädlingsbekämpfungsmittel

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4555573A (en) * 1983-11-15 1985-11-26 Riker Laboratories, Inc. Certain 6-benzamidomethyl-2(1H)-pyridone derivatives
AR241530A1 (es) * 1984-12-21 1992-08-31 Ciba Geigy A G Cesionaria De F 1,2,4-triazoles, composicion para el control de pestes y procedimiento para la preparacion de 1,2,4-triazoles.
US4931561A (en) * 1987-07-29 1990-06-05 Koei Chemical Co., Ltd. Process for preparing nitriles
EP0361791B1 (de) * 1988-09-26 1995-11-08 Smithkline Beecham Farmaceutici S.p.A. Azacyclische Verbindungen, verwendbar als Arzneimittel
DE4019420A1 (de) * 1990-06-19 1992-01-02 Bayer Ag Polycyanopyrimidine und verfahren zu ihrer herstellung
US5656253A (en) * 1990-09-14 1997-08-12 Mallinckrodt Medical, Inc. Ligands useful in radiographic imaging
JP2994182B2 (ja) * 1992-07-23 1999-12-27 石原産業株式会社 アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤
HUT71553A (en) * 1992-08-06 1995-12-28 Warner Lambert Co 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties
MX9304801A (es) * 1992-08-06 1997-06-28 Warner Lambert Co 2-toindoles (selenoidoles) disulfuros (seleniduros) relacinados, los cuales inhiben a las proteinas tirosina cinasas y los cuales tienen propiedades anti-tumorales.
MX9705970A (es) * 1995-02-10 1997-11-29 Basf Ag Inhibidores de trombina.
GB9510459D0 (en) * 1995-05-24 1995-07-19 Zeneca Ltd Bicyclic amines
US5883254A (en) * 1996-11-08 1999-03-16 Hoffmann-La Roche Inc. Process for making pyrimidine derivatives
GB9624611D0 (en) * 1996-11-26 1997-01-15 Zeneca Ltd Bicyclic amine compounds
AU719147B2 (en) * 1996-11-26 2000-05-04 Zeneca Limited 8-azabicyclo{3.2.1}octane-, 8-azabicyclo{3.2.1}oct-6-ene-, 9-azabicyclo{3.3.1} nonane-, 9-aza-3-oxabicyclo{3.3.1}nonane- and 9-aza-3-thiabicyclo{3.3.1}nonane derivatives, their preparation and their use as insecticides
DE69925355T2 (de) * 1998-08-31 2006-01-12 Nof Corp. Hydrophobierte und sehr reine polysaccharide und verfahren zu deren herstellung
EP1114030B1 (de) * 1998-09-15 2005-06-01 Syngenta Participations AG als herbicide verwendbare pyridin-ketone
US6673799B1 (en) * 1998-09-22 2004-01-06 Yamanouchi Pharmaceutical Co. Ltd. Cyanophenyl derivative
UA58636C2 (uk) * 1999-06-04 2003-08-15 Мерк Енд Ко., Інк. Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням
EP1189618A4 (de) * 1999-06-04 2002-06-19 Merck & Co Inc Thrombinhemmer
GB9919588D0 (en) * 1999-08-18 1999-10-20 Hoechst Schering Agrevo Gmbh Fungicidal compounds
EA200200422A1 (ru) * 1999-09-30 2002-10-31 Ньюроджен Корпорейшн НЕКОТОРЫЕ АЛКИЛЕНДИАМИНОЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-а]-1,5-ПИРИМИДИНЫ И ПИРАЗОЛО[1,5-а]-1,3,5-ТРИАЗИНЫ
CA2391012A1 (en) * 1999-11-23 2001-05-31 Merck & Co., Inc. Pyrazinone thrombin inhibitors
WO2001064674A1 (en) * 2000-03-01 2001-09-07 Janssen Pharmaceutica N.V. 2,4-disubstituted thiazolyl derivatives
AU2001262105A1 (en) * 2000-03-22 2001-10-03 Bayer Cropscience Gmbh Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides
US7074742B2 (en) * 2000-09-18 2006-07-11 E. I. Du Pont De Nemours And Company Pyridinyl amides and imides for use as fungicides
US7015236B2 (en) * 2001-11-21 2006-03-21 Sankyo Agro Company, Limited N-heteroarylnicotinamide derivatives
SE0104140D0 (sv) * 2001-12-07 2001-12-07 Astrazeneca Ab Novel Compounds
EP1400275B1 (de) * 2002-08-22 2006-09-27 Honeywell Normalair-Garrett (Holdings) Limited Verfahren zum Einbau eines Molekularsieb-Gasanreicherungsystems
US7150550B2 (en) * 2004-09-29 2006-12-19 Lear Corporation Automotive map pocket having an electroluminescent lamp and method of making the same

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0692482A2 (de) * 1994-07-12 1996-01-17 Nihon Bayer Agrochem K.K. 1-Pyridyltetrazolinon-Derivate
WO1998057969A1 (de) * 1997-06-16 1998-12-23 Hoechst Schering Agrevo Gmbh 4-haloalkyl-3-heterocyclylpyridine und 4-haloalkyl-5-heterocyclylpyrimidine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
DE19858193A1 (de) * 1998-12-17 2000-06-21 Aventis Cropscience Gmbh 4-Trifluormethyl-3-oxadiazolylpyridine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
EP1140921A1 (de) * 1998-12-17 2001-10-10 Aventis CropScience GmbH 4-trifluormethyl-3-oxazolylpyridine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
WO2001014373A1 (en) * 1999-08-20 2001-03-01 Syngenta Participations Ag Derivatives of trifluoromethylpyri(mi)dine
WO2002012229A1 (de) * 2000-08-08 2002-02-14 Bayer Cropscience Gmbh Heterocyclylalkylazol-derivate und ihre verwendung als schädlingsbekämpfungsmittel

Also Published As

Publication number Publication date
JP2007536307A (ja) 2007-12-13
MXPA06013135A (es) 2007-02-28
EA200602038A1 (ru) 2007-04-27
KR20070033980A (ko) 2007-03-27
CN1980926A (zh) 2007-06-13
ZA200609252B (en) 2008-06-25
TW200607451A (en) 2006-03-01
US20080293674A1 (en) 2008-11-27
BRPI0511025A (pt) 2007-11-27
DE102004022897A1 (de) 2005-12-08
WO2005113553A2 (de) 2005-12-01
CA2566074A1 (en) 2005-12-01
EP1751152A2 (de) 2007-02-14

Similar Documents

Publication Publication Date Title
WO2005113553A3 (de) Azinyl-imidazoazine und azinylcarboxamide
WO2003084922A8 (de) Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
WO2006092213A8 (de) Pyrazolylcarboxanilide
NL300933I2 (nl) Letermovir
WO2004074244A3 (en) Pyrimidine compounds
NZ539841A (en) Hydroxyethylamine derivatives for the treatment of alzheimer's disease
WO2008030511A3 (en) Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes
WO2003059903A3 (de) Substituierte 4-aminopyridin-derivate als schädlingsbekämpfungsmittel
WO2004108686A3 (en) Benzimidazole compounds having hypoglycemic activity
WO2006099943A8 (de) Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2004094386A8 (en) Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)
MX2007000392A (es) Derivados de 2-pirrolidona sustituida como fungicidas e insecticidas.
MX2007003031A (es) Compuestos heteroarilo para uso como betamimeticos en el tratamiento de enfermedades de vias respiratorias.
ZA200408410B (en) Pesticidal pyridinecarboxamide derivatives
WO2001070692A3 (de) Heterocyclische acylsulfimide,verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
MXPA06004308A (es) Isopentilcarboxanilidas para la lucha contra los microorganismos indeseables.
WO2009015369A3 (en) Isophthalamide derivatives inhibiting beta-secretase activity
EA200600778A1 (ru) 1,3-диметилбутилкарбоксанилиды для борьбы с нежелательными микроорганизмами
WO2004073675A8 (de) Kosmetische zusammensetzung mit whitening-effekt, verfahren zu ihrer herstellung und ihre verwendung
WO2008023003A8 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
WO2005061496A8 (en) Aminopyridine-derivatives as inductible no-synthase inhibitors
WO2006061215A3 (de) 2-alkyl-cycloalk(en)yl-carboxamide
WO2002088125A3 (de) Triazolopyrimidine mit fungizider wirkung
WO2003024996A3 (de) Antibakterielle makrozyklen
WO2005004606A3 (en) Pyridinylanilides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005737913

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006/09252

Country of ref document: ZA

Ref document number: 2566074

Country of ref document: CA

Ref document number: 200609252

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 2007511976

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 12006502235

Country of ref document: PH

Ref document number: PA/a/2006/013135

Country of ref document: MX

Ref document number: 06114692

Country of ref document: CO

Ref document number: 6662/DELNP/2006

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 1020067024976

Country of ref document: KR

Ref document number: 1020067025005

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 1200602012

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: 200602038

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 200580022514.6

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2005737913

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1020067024976

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 11579703

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1020067025005

Country of ref document: KR

ENP Entry into the national phase

Ref document number: PI0511025

Country of ref document: BR